Skip to main content
Top
Published in: Trials 1/2014

Open Access 01-12-2014 | Methodology

Making a decision about trial participation: the feasibility of measuring deliberation during the informed consent process for clinical trials

Authors: Katie Gillies, Glyn Elwyn, Jonathan Cook

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

Informed consent of trial participants is both an ethical and a legal requirement. When facing a decision about trial participation, potential participants are provided with information about the trial and have the opportunity to have any questions answered before their degree of ‘informed-ness’ is assessed, usually subjectively, and before they are asked to sign a consent form. Currently, standardised methods for assessing informed consent have tended to be focused on aspects of understanding and associated outcomes, rather than on the process of consent and the steps associated with decision-making.

Methods

Potential trial participants who were approached regarding participation in one of three randomised controlled trials were asked to complete a short questionnaire to measure their deliberation about trial participation. A total of 136 participants completed the 10-item questionnaire (DelibeRATE) before they made an explicit decision about trial participation (defined as signing the clinical trial consent form). Overall DelibeRATE scores were compared and investigated for differences between trial consenters and refusers.

Results

No differences in overall DelibeRATE scores were identified. In addition, there was no significant difference between overall score and the decision to participate, or not, in the parent trial.

Conclusions

To our knowledge, this is the first study to prospectively measure the deliberation stage of the informed consent decision-making process of potential trial participants across different conditions and clinical areas. Although there were no differences detected in overall scores or scores of trial consenters and refusers, we did identify some interesting findings. These findings should be taken into consideration by those designing trials and others interested in developing and implementing measures of potential trial participants decision making during the informed consent process for research.

Trial registration

International Standard Randomised Controlled Trial Number (ISRCTN) Register ISRCTN60695184 (date of registration: 13 May 2009), ISRCTN80061723 (date of registration: 8 March 2010), ISRCTN69423238 (date of registration: 18 November 2010)
Appendix
Available only for authorised users
Literature
1.
go back to reference Beauchamp TL, Childress JF: Principles of Biomedical Ethics. 2001, Oxford: Oxford University Press, 5 Beauchamp TL, Childress JF: Principles of Biomedical Ethics. 2001, Oxford: Oxford University Press, 5
4.
go back to reference Flory J, Emanuel E: Interventions to improve research participants’ understanding in informed consent for research: a systematic review. JAMA. 2000, 6 (292): 1593-1601. Flory J, Emanuel E: Interventions to improve research participants’ understanding in informed consent for research: a systematic review. JAMA. 2000, 6 (292): 1593-1601.
5.
go back to reference Nishimura A, Carey J, Erwin PJ, Tilburt JC, Murad MH, McCormick JB: Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics. 2013, 14: 28-CrossRefPubMedPubMedCentral Nishimura A, Carey J, Erwin PJ, Tilburt JC, Murad MH, McCormick JB: Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics. 2013, 14: 28-CrossRefPubMedPubMedCentral
6.
go back to reference Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC: Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst. 2001, 93: 139-147.CrossRefPubMed Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC: Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst. 2001, 93: 139-147.CrossRefPubMed
7.
go back to reference Guarino P, Lamping DL, Elbourne D, Carpenter J, Peduzzi P: A brief measure of perceived understanding of informed consent in a clinical trial was validated. J Clin Epidemiol. 2006, 59: 608-614.CrossRefPubMed Guarino P, Lamping DL, Elbourne D, Carpenter J, Peduzzi P: A brief measure of perceived understanding of informed consent in a clinical trial was validated. J Clin Epidemiol. 2006, 59: 608-614.CrossRefPubMed
8.
go back to reference Miller JD, Kotowski MR, Comis RL, Smith SW, Silk KJ, Colaizzi DD, Kimmel LG: Measuring cancer clinical trial understanding. Health Commun. 2011, 26: 82-93.CrossRefPubMed Miller JD, Kotowski MR, Comis RL, Smith SW, Silk KJ, Colaizzi DD, Kimmel LG: Measuring cancer clinical trial understanding. Health Commun. 2011, 26: 82-93.CrossRefPubMed
9.
go back to reference Mexas F, Efron A, Luiz RR, Cailleaux-Cezar M, Chaisson RE, Conde MB: Understanding and retention of trial-related information among participants in a clinical trial after completing the informed consent process. Clin Trials. 2013, 11: 70-76.CrossRefPubMed Mexas F, Efron A, Luiz RR, Cailleaux-Cezar M, Chaisson RE, Conde MB: Understanding and retention of trial-related information among participants in a clinical trial after completing the informed consent process. Clin Trials. 2013, 11: 70-76.CrossRefPubMed
10.
go back to reference Sugarman J, Lavori PW, Boeger M, Cain C, Edsond R, Morrison V, Yeh SS: Evaluating the quality of informed consent. Clin Trials. 2005, 2: 34-41.CrossRefPubMed Sugarman J, Lavori PW, Boeger M, Cain C, Edsond R, Morrison V, Yeh SS: Evaluating the quality of informed consent. Clin Trials. 2005, 2: 34-41.CrossRefPubMed
11.
go back to reference Hutchison C, Cowan C, Paul J: Patient understanding of research: developing and testing of a new questionnaire. Eur J Cancer Care. 2007, 16: 187-195.CrossRef Hutchison C, Cowan C, Paul J: Patient understanding of research: developing and testing of a new questionnaire. Eur J Cancer Care. 2007, 16: 187-195.CrossRef
12.
go back to reference Appelbaum PS, Anatchkova M, Albert K, Dunn LB, Lidz CW: Therapeutic misconception in research subjects: development and validation of a measure. Clin Trials. 2012, 9: 748-761.CrossRefPubMedPubMedCentral Appelbaum PS, Anatchkova M, Albert K, Dunn LB, Lidz CW: Therapeutic misconception in research subjects: development and validation of a measure. Clin Trials. 2012, 9: 748-761.CrossRefPubMedPubMedCentral
13.
go back to reference Gillies K, Entwistle V: Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision. J Med Ethics. 2012, 38: 751-756.CrossRefPubMed Gillies K, Entwistle V: Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision. J Med Ethics. 2012, 38: 751-756.CrossRefPubMed
14.
go back to reference Elwyn G, Miron-Shatz T: Deliberation before determination: the definition and evaluation of good decision making. Health Expect. 2010, 13: 139-147.CrossRefPubMed Elwyn G, Miron-Shatz T: Deliberation before determination: the definition and evaluation of good decision making. Health Expect. 2010, 13: 139-147.CrossRefPubMed
15.
go back to reference Mills N, Donovan JL, Wade J, Hamdy FC, Neal DE, Lane JA: Exploring treatment preferences facilitated recruitment to randomized controlled trials. J Clin Epidemiol. 2011, 64: 1127-1136.CrossRefPubMedPubMedCentral Mills N, Donovan JL, Wade J, Hamdy FC, Neal DE, Lane JA: Exploring treatment preferences facilitated recruitment to randomized controlled trials. J Clin Epidemiol. 2011, 64: 1127-1136.CrossRefPubMedPubMedCentral
16.
go back to reference Stryker JE, Wray RJ, Emmons KM, Winer E, Demetri G: Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. Patient Educ Couns. 2006, 63: 104-109.CrossRefPubMed Stryker JE, Wray RJ, Emmons KM, Winer E, Demetri G: Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. Patient Educ Couns. 2006, 63: 104-109.CrossRefPubMed
17.
go back to reference Miller SM, Hudson SV, Egleston BL, Manne S, Buzaglo JS, Devarajan K, Fleisher L, Millard J, Solarino N, Trinastic J, Meropol NJ: The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial. Psychooncology. 2013, 22: 481-489.CrossRefPubMed Miller SM, Hudson SV, Egleston BL, Manne S, Buzaglo JS, Devarajan K, Fleisher L, Millard J, Solarino N, Trinastic J, Meropol NJ: The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial. Psychooncology. 2013, 22: 481-489.CrossRefPubMed
18.
go back to reference Sivell S, Edwards A, Manstead AS, Reed MW, Caldon L, Collins K, Clements A, Elwyn G, BresDex Group: Increasing readiness to decide and strengthening behavioral intentions: evaluating the impact of a web-based patient decision aid for breast cancer treatment options. Patient Educ Couns. 2012, 88: 209-217. (BresDex: http://www.bresdex.com)CrossRefPubMed Sivell S, Edwards A, Manstead AS, Reed MW, Caldon L, Collins K, Clements A, Elwyn G, BresDex Group: Increasing readiness to decide and strengthening behavioral intentions: evaluating the impact of a web-based patient decision aid for breast cancer treatment options. Patient Educ Couns. 2012, 88: 209-217. (BresDex: http://​www.​bresdex.​com)CrossRefPubMed
19.
go back to reference Joseph G, Dohan D: Diversity of participants in clinical trials in an academic medical center: the role of the ‘good study patient’?. Cancer. 2009, 115: 608-615.CrossRefPubMed Joseph G, Dohan D: Diversity of participants in clinical trials in an academic medical center: the role of the ‘good study patient’?. Cancer. 2009, 115: 608-615.CrossRefPubMed
20.
go back to reference Donovan JL, Paramasivan S, de Salis I, Toerien M: Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials. Trials. 2014, 15: 5-CrossRefPubMedPubMedCentral Donovan JL, Paramasivan S, de Salis I, Toerien M: Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials. Trials. 2014, 15: 5-CrossRefPubMedPubMedCentral
21.
go back to reference Gillies K, Huang W, Skea Z, Brehaut J, Cotton S: Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation. Trials. 2014, 15: 62-CrossRefPubMedPubMedCentral Gillies K, Huang W, Skea Z, Brehaut J, Cotton S: Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation. Trials. 2014, 15: 62-CrossRefPubMedPubMedCentral
22.
go back to reference Juraskova I, Butow P, Lopez A, Secombe M, Coates A, Boyle F, McCarthy N, Reaby L, Forbes JF: Improving informed consent: a pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expect. 2008, 11: 252-262.CrossRefPubMed Juraskova I, Butow P, Lopez A, Secombe M, Coates A, Boyle F, McCarthy N, Reaby L, Forbes JF: Improving informed consent: a pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expect. 2008, 11: 252-262.CrossRefPubMed
23.
go back to reference Sundaresan P, Turner S, Kneebone A, Pearse M, Butow P: Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-ROG 08.03). Radiother Oncol. 2011, 101: 521-524.CrossRefPubMed Sundaresan P, Turner S, Kneebone A, Pearse M, Butow P: Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-ROG 08.03). Radiother Oncol. 2011, 101: 521-524.CrossRefPubMed
24.
go back to reference Abhyankar P, Bekker HL, Summers BA, Velikova G: Why values elicitation techniques enable people to make informed decisions about cancer trial participation. Health Expect. 2011, 14: 20-32.CrossRefPubMed Abhyankar P, Bekker HL, Summers BA, Velikova G: Why values elicitation techniques enable people to make informed decisions about cancer trial participation. Health Expect. 2011, 14: 20-32.CrossRefPubMed
25.
go back to reference Brehaut JC, Lott A, Fergusson DA, Shojania KG, Kimmelman J, Saginur R: Can patient decision aids help people make good decisions about participating in clinical trials? A study protocol. Implement Sci. 2008, 23: 38-CrossRef Brehaut JC, Lott A, Fergusson DA, Shojania KG, Kimmelman J, Saginur R: Can patient decision aids help people make good decisions about participating in clinical trials? A study protocol. Implement Sci. 2008, 23: 38-CrossRef
26.
Metadata
Title
Making a decision about trial participation: the feasibility of measuring deliberation during the informed consent process for clinical trials
Authors
Katie Gillies
Glyn Elwyn
Jonathan Cook
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-307

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue